OPPENHEIMER ASSET MANAGEMENT INC. - IMMUNOMEDICS INC ownership

IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 418 filers reported holding IMMUNOMEDICS INC in Q3 2020. The put-call ratio across all filers is 0.82 and the average weighting 1.3%.

Quarter-by-quarter ownership
OPPENHEIMER ASSET MANAGEMENT INC. ownership history of IMMUNOMEDICS INC
ValueSharesWeighting
Q3 2020$2,285,000
+91.9%
26,872
-20.0%
0.04%
+76.0%
Q2 2020$1,191,000
+168.8%
33,611
+2.3%
0.02%
+127.3%
Q1 2020$443,000
-36.4%
32,844
-0.2%
0.01%
-26.7%
Q4 2019$696,000
+100.0%
32,894
+25.5%
0.02%
+87.5%
Q3 2019$348,000
-5.9%
26,209
-1.7%
0.01%0.0%
Q2 2019$370,000
-37.4%
26,663
-13.3%
0.01%
-38.5%
Q1 2019$591,00030,7620.01%
Other shareholders
IMMUNOMEDICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Avoro Capital Advisors LLC 10,488,076$92,610,00011.69%
First Light Asset Management, LLC 2,048,643$18,090,0006.07%
Foresite Capital Management III, LLC 1,940,850$17,138,0005.60%
DAFNA Capital Management LLC 637,700$5,631,0004.02%
ACUTA CAPITAL PARTNERS, LLC 1,600,000$14,128,0003.95%
Opaleye Management Inc. 900,000$7,947,0003.32%
Ghost Tree Capital, LLC 1,200,000$10,596,0002.20%
Iguana Healthcare Management, LLC 325,000$2,870,0001.62%
Healthcare Value Capital, LLC 100,000$883,0001.59%
Palo Alto Investors LP 3,010,466$26,582,0001.24%
View complete list of IMMUNOMEDICS INC shareholders